Funding for this research was provided by:
New York University Provost Mega Grants Initiative
Article History
Accepted: 14 October 2022
First Online: 12 November 2022
Declarations
:
: No authors report a conflict of interest. The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr. Halkitis and Dr. Krause have received research funding from Merck and Bristol Myers Squibb and Dr. Brennan-Ing has received research support from Gilead Sciences and is a consultant on educational materials for Theratech Inc.
: All study protocols were initially approved by the New York University Institutional Review Board in 2017 and subsequently by the Rutgers University Institutional Review Board in 2018.
: All participants provided written consent to participating in the study after learning about the study procedures.
: Not applicable.